Merck KGAA (MRK) Nil Par Value
€0.25
(0.18%)
- Add to watchlist
- This stock can be held in a
€0.25
(0.18%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
€0.25
(0.18%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Merck shares plunge on failure of cancer drug trial
25 June 2024 13:38
(Sharecast News) - Shares of German chemical and pharmaceutical firm Merck were falling sharply on Tuesday, after it announced that a trial for its head and neck cancer drug xevinapant had been halted due to...
-
Merck shares sink after MS drug fails in latest trial
6 December 2023 10:35
(Sharecast News) - Shares in German science and technology giant Merck plunged 13% on Wednesday after its multiple sclerosis drug didn't meet expectations in a late-stage trial.
-
Merck shares fall as FDA pauses new patients on MS drug trial
12 April 2023 11:52
(Sharecast News) - Shares in German pharmaceutical company Merck fell on Wednesday after the US Food and Drug Administration (FDA) placed a temporary hold on use of its multiple sclerosis evobrutinib drug on...
Company announcements Announcements
No company announcements about Merck KGAA Nil Par Value were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.